Statistics for Design Therapeutics, (id:8108 DSGN)


Valuation metrics

Market cap
328.40M
Enterprise value
89.31M
Trailing P/E (ttm)
-4.72
Forward P/E
-4.79
PEG ratio
-4.79
Price/Sales (ttm)
Price/Book (mrq)
1.30
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.48

Overview

Shares outstanding
56.62M
Float
25.24M
Shares short
2.59M
% Held by insiders
0.36%
% Held by institutions
0.56%
Average volume (10 days)
204.39K
Average volume (90 days)

Price summary

52-Week low
2.13
52-Week high
7.77
52-Week change
61.03%
Beta
1.83
50-Day moving average
5.49
200-Day moving average
4.20

Dividends and splits

Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date

Financials

Fiscal year
Fiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-13.54%
Return on equity
-17.78%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-60,225,000.00
Net income to common (ttm)
-47,779,000.00
Diluted EPS (ttm)
-0.85
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
254.07M
Total cash per share (mrq)
4.49
Total debt (mrq)
2.52M
Total Debt/Equity (mrq)
1.00
Current ratio (mrq)
3.46K%
Book value per share (mrq)
4.46
Cash flow
Cash flow statement
-46,043,000.00
Levered free cash flow (LFCF)
-30,067,250.00

CleverShares.com|
2024 ©

1.0.9094.36724